Targeted Chemotherapy for Breast Cancer Using an Intelligent Doxorubicin-Loaded Hexapeptide Hydrogel.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Targeted Chemotherapy for Breast Cancer Using an Intelligent Doxorubicin-Loaded Hexapeptide Hydrogel.
- Published In:
- Journal of biomedical nanotechnology, 16(6), 842-852 (2020)
- Authors:
- Luo, Shiyao, Zhu, Ying(3), Li, Yiping, Chen, Li, Lv, Shunzhong, Zhang, Yuan, Ge, Liang, Zhou, Wenwu
- Database ID:
- RPEP-04970
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04970APA
Luo, Shiyao; Zhu, Ying; Li, Yiping; Chen, Li; Lv, Shunzhong; Zhang, Yuan; Ge, Liang; Zhou, Wenwu. (2020). Targeted Chemotherapy for Breast Cancer Using an Intelligent Doxorubicin-Loaded Hexapeptide Hydrogel.. Journal of biomedical nanotechnology, 16(6), 842-852. https://doi.org/10.1166/jbn.2020.2935
MLA
Luo, Shiyao, et al. "Targeted Chemotherapy for Breast Cancer Using an Intelligent Doxorubicin-Loaded Hexapeptide Hydrogel.." Journal of biomedical nanotechnology, 2020. https://doi.org/10.1166/jbn.2020.2935
RethinkPeptides
RethinkPeptides Research Database. "Targeted Chemotherapy for Breast Cancer Using an Intelligent..." RPEP-04970. Retrieved from https://rethinkpeptides.com/research/luo-2020-targeted-chemotherapy-for-breast
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.